| Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies E Hormones, Prostate Cancer Collaborative Group JNCI: Journal of the National Cancer Institute 100 (3), 170-183, 2008 | 857 | 2008 |
| Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. RAW Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ ... Lancet Oncology 11 (6), 530-542, 2010 | 661 | 2010 |
| Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo V Mohamed-Ali, S Goodrick, K Bulmer, JMP Holly, JS Yudkin, ... American Journal of Physiology-Endocrinology and Metabolism 277 (6), E971-E975, 1999 | 485 | 1999 |
| Height, leg length, and cancer risk: a systematic review D Gunnell, M Okasha, G Davey Smith, SE Oliver, J Sandhu, JMP Holly Epidemiologic reviews 23 (2), 313-342, 2001 | 465 | 2001 |
| Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies AW Roddam, NE Allen, P Appleby, TJ Key, L Ferrucci, HB Carter, ... Annals of internal medicine 149 (7), 461-471, 2008 | 447 | 2008 |
| Circulating insulin‐like growth factor peptides and prostate cancer risk: a systematic review and meta‐analysis MA Rowlands, D Gunnell, R Harris, LJ Vatten, JMP Holly, RM Martin International journal of cancer 124 (10), 2416-2429, 2009 | 329 | 2009 |
| Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight RM Freathy, DO Mook-Kanamori, U Sovio, I Prokopenko, NJ Timpson, ... Nature genetics 42 (5), 430-435, 2010 | 282 | 2010 |
| Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner ZP Gill, CM Perks, PV Newcomb, JMP Holly Journal of Biological Chemistry 272 (41), 25602-25607, 1997 | 274 | 1997 |
| Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments JMP Holly, JAH Wass Journal of endocrinology 122 (3), 611-618, 1989 | 270 | 1989 |
| The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness SC Davies, JAH Wass, RJM Ross, AM Cotterill, CR Buchanan, ... Journal of Endocrinology 130 (3), 469-NP, 1991 | 251 | 1991 |
| The impact of childhood body mass index on timing of puberty, adult stature and obesity: a follow-up study based on adolescent anthropometry recorded at Christ's Hospital (1936 … J Sandhu, Y Ben-Shlomo, TJ Cole, J Holly, G Davey Smith International journal of obesity 30 (1), 14-22, 2006 | 249 | 2006 |
| Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk ES Schernhammer, JM Holly, MN Pollak, SE Hankinson Cancer Epidemiology Biomarkers & Prevention 14 (3), 699-704, 2005 | 236 | 2005 |
| ORCADIAN VARIATION OF GH‐INDEPENDENT IGF‐BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN? JMP Holly, RA Biddlecombe, DB Dunger, JA Edge, SA Amiel, R Howell, ... Clinical endocrinology 29 (6), 667-675, 1988 | 223 | 1988 |
| Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease A Donaghy, R Ross, A Gimson, SC Hughes, J Holly, R Williams Hepatology 21 (3), 680-688, 1995 | 218 | 1995 |
| EFFECTS OF LUTEINIZING HORMONE, INSULIN, INSULIN‐LIKE GROWTH FACTOR‐I AND INSULINLIKE GROWTH FACTOR SMALL BINDING PROTEIN 1 IN THE POLYCYSTIC OVARY SYNDROME GS Conway, HS Jacobs, JMP Holly, JAH Wass Clinical Endocrinology 33 (5), 593-603, 1990 | 192 | 1990 |
| A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in UK populations TM Frayling, AT Hattersley, A McCarthy, J Holly, SMS Mitchell, AL Gloyn, ... Diabetes 51 (7), 2313-2316, 2002 | 189 | 2002 |
| The role of insulin-like growth factor binding proteins J Holly, C Perks Neuroendocrinology 83 (3-4), 154-160, 2006 | 184 | 2006 |
| Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II ES Schernhammer, JM Holly, DJ Hunter, MN Pollak, SE Hankinson Endocrine-Related Cancer 13 (2), 583-592, 2006 | 181 | 2006 |
| Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review O Fletcher, L Gibson, N Johnson, DR Altmann, JMP Holly, A Ashworth, ... Cancer Epidemiology Biomarkers & Prevention 14 (1), 2-19, 2005 | 177 | 2005 |
| Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding … KW Colston, CM Perks, SP Xie, JM Holly Journal of Molecular Endocrinology 20 (1), 157-162, 1998 | 176 | 1998 |
David GunnellProfessor of Epidemiology, University of BristolVerified email at bristol.ac.uk
